Diagnosis of systemic scleroderma can often be very challenging. Diagnosis is done by a combination of lab tests (ANA/antibodies) and clinical symptoms such as skin thickening, puffy hands, telangiectasias. Additional symptoms [...]
The 20th annual Scleroderma Foundation national patient education conference was held over this past weekend in Philadelphia. As always, it was excellent and very informative. Attendance was over 700 people, a [...]
This past March, after we announced that the research paper “Therapeutic Plasma Exchange for the Treatment of Systemic Sclerosis: A Comprehensive Review and Analysis” had been published in the Journal [...]
We are pleased to announce that the Scleroderma Education Project has just started a new YouTube educational channel. Our first video is an overview of the research literature on therapeutic plasma [...]
Scleroderma News just ran a feature story on our newly published research paper titled “Therapeutic Plasma Exchange for the Treatment of Systemic Sclerosis: A Comprehensive Review and Analysis”. The paper [...]
After nearly nine months of effort involving an amazing team of volunteers, the brand-new Scleroderma Education Project website is now live! When the first version of the Scleroderma FAQ™ was [...]
We are pleased to announce that a new research paper titled Therapeutic plasma exchange in the treatment of systemic sclerosis: A comprehensive review and analysis has just been published online [...]
For those of you interested in autologous stem cell transplants, this paper was just published open access in "Clinical Rheumatology": https://link.springer.com/article/10.1007/s10067-017-3954-5. Autologous HSCT may be an appropriate treatment option to [...]
This article was supplied to me courtesy of Dr. Allan Metzger*, Medical Director of RDL Reference Lab in Los Angeles. It is an anecdotal guest column in the publication "The [...]
Thomas A. Medsger, Jr., MD University of Pittsburg School of Medicine I just found a recent presentation by Dr. Thomas Medsger on the clinical significance of autoantibodies in systemic scleroderma. [...]
